Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Solentim wins place in Deloitte UK Technology Fast 50

Solentim
Posted on: 16 Nov 18

Solentim named as one of the top 50 fastest growing UK technologies companies of 2018

Wimborne, UK, 16th November 2018 / Sciad NewswireSolentim, a life sciences company, has won a place in this year’s Deloitte’s UK Technology Fast 50 list following a 1,106% revenue growth over the past 4 years. Solentim specialises in products used by developers of new biotherapeutic medicines, such as monoclonal antibodies for the treatment of cancer. The Company claimed 27th place at an exclusive gala awards event in London last night.

The Deloitte UK Technology Fast 50 is one of the UK's foremost technology award programmes, celebrating innovation and entrepreneurship. Now in its 21st successful year, it is a ranking of the UK’s 50 fastest growing technology companies, driven by leading intellectual property and based on revenue growth over the last four years. 

The announcement recognises the commercial success of Solentim’s VIPS™ and Cell Metric® products, which have increased the speed of development and regulatory assurance of novel biotherapeutic and biosimilar drugs developed in mammalian cells, a process called Cell Line Development. 

Receiving this prestigious accolade, Aaron Figg, Co-Founder and Director of Solentim, commented, “We’re really proud to have built a company over the last eight years which has become an industry leader, serving customers on a truly global scale. With the advent and adoption by our customers of the latest biological engineering tools like CRISPR and CAR-T, which are already showing astounding results in the treatment of patients, this is a very exciting time and market space for Solentim. This award is testament to our highly skilled and committed team, and we could not be more pleased to have our efforts and success recognised by Deloitte, especially as it closely follows us winning two Queens Awards for Enterprise earlier this year.” 

Ends

For further information, contact:

Corporate Contact:
Ian Taylor, Sales & Marketing Director
Solentim Ltd
T: +44 (0)1202 051813
E: ian.taylor@solentim.com

PR Contact:
Emma Pickup / Juliette Craggs
Sciad Communications Ltd
T: +44 (0)20 7470 8801
E: solentim@sciad.com

Notes to Editors

Photograph courtesy of Delloite, (left to right): Aaron Figg, Director, and Ian Taylor, Sales & Marketing Director

About Solentim
Solentim enables its life science industry customers to develop a greater number of more effective pharmaceuticals to help patients live healthier, for longer. We do this through designing and manufacturing highly innovative instruments that facilitate the process of commercial cell line development. This phase of biopharmaceutical production is a high-value process which is intrinsically expensive and time-consuming. Our solutions significantly shorten the upstream cell line development workflow process and therefore make drug production faster and more cost effective. Our products; Cell Metric® and VIPS™ represent the next generation of single cell printing and provide documented proof of monoclonality for the FDA and other regulatory bodies. All of the world’s top ten pharmaceutical companies use Solentim products. Established in 2010 and with global headquarters in Dorset, UK; the organisation employs over 40 people across the UK, Europe, Asia and the USA.

About Deloitte
In this press release references to “Deloitte” are references to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”) a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see deloitte.com/about for a detailed description of the legal structure of DTTL and its member firms.

Deloitte LLP is a subsidiary of Deloitte NWE LLP, which is a member firm of DTTL, and is among the UK's leading professional services firms.

The information contained in this press release is correct at the time of going to press. For more information, please visit www.deloitte.co.uk.

About the Deloitte UK Technology Fast 50
The Deloitte UK Technology Fast 50 is one of the UK’s foremost technology award programmes. Now in its twentieth year, it is a ranking of the country’s 50 fastest-growing technology companies, based on financial performance over the last four years. The UK Fast 50 awards are all about growth driven by leading intellectual property and are a celebration of innovation and entrepreneurship. The UK Technology Fast 50 is part of an international programme run by Deloitte and qualifying entrants of the UK Fast 50 will be put forward to the Deloitte Technology Fast 500 EMEA (Europe, Middle East and Africa) programme. Previous winners have come from across the UK, are both large and small, and included some of the most dynamic players in all areas of technology, from internet specialists to biotech, digital media technology to life sciences, computers to semiconductors and software to telecommunications.

For more information visit www.fast50.co.uk.

Editor's Details

Emma Pickup
Sciad Communications
+44(0)20 7470 8801
solentim@sciad.com

Last updated on: 16/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.